TestCard
Latest round
- Seed
Last raised
- Sep 2019
Total raised
- $1.6M
Investors
- 3
About TestCard
TestCard Ltd. develops innovative digital diagnostic testing solutions, enabling accurate health assessments through its ClearScreen platform.TestCard Ltd. was founded in 2017 in Scarborough, UK, focusing on digital health solutions. The company has pivoted to enhance its product offerings, particularly through the ClearScreen platform, which allows for the efficient reading and reporting of test results using smart devices. The founders include Andrew Botham, Lucas Heron, and Luke Heron, with Chris Craig-Wood serving as the CEO.TestCard specializes in digital diagnostic testing solutions, primarily through its flagship product, the ClearScreen platform. This innovative technology transforms camera-enabled smart devices into clinical-grade scanners capable of accurate reading, recording, and reporting of test results. The ClearScreen app is designed for both healthcare professionals and laypersons, ensuring ease of use in various settings, including hospitals, clinics, and at-home testing environments. The company has established partnerships with key players such as the NHS and Roche, making its services accessible across the UK and other international markets, adapting to the needs of patients, healthcare providers, and research organizations.TestCard generates revenue through partnerships and subscriptions related to its diagnostic technology services, specifically the ClearScreen platform. The company engages in B2B transactions, collaborating with healthcare institutions and organizations such as the NHS and Roche, while also providing at-home testing solutions directly to consumers. Revenue streams include licensing fees for the use of the ClearScreen technology, support services, integration of their app into existing medical systems, and provisions for necessary hardware. These transactions are structured to facilitate seamless implementation and ongoing support, allowing healthcare providers to utilize TestCard’s technology effectively within their workflows.In April 2022, TestCard Ltd. The company plans to use this investment to further commercialize its existing product portfolio and launch new testing products, including diabetes, pregnancy, chronic kidney disease (CKD), and flu testing. TestCard aims to expand its market presence, targeting additional regions to enhance its service accessibility and effectiveness.
Who invested in TestCard
3 investors across 2 rounds
See all investors in TestCard
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TestCard
Who invested in TestCard?
TestCard has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TestCard raised?
TestCard has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did TestCard last raise money?
TestCard's most recent round on record is a Seed, in Sep 2019.
What does TestCard do?
TestCard is a healthcare it company.
Where is TestCard headquartered?
TestCard is headquartered in Scarborough, UK.
Which VCs invest in companies like TestCard?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back healthcare it companies at TestCard's stage. Their profiles are linked below.
VCs backing healthcare it startups at Seed
Raising like TestCard? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.